Chemotherapy with bevacizumab followed by bevacizumab maintenance vs chemotherapy alone
Adverse events (grade ≥ 3) · platinum‐sensitive recurrent EOC
Chemotherapy with bevacizumab followed by bevacizumab maintenance leads to higher any adverse event (grade ≥3) compared with chemotherapy alone (high certainty).
1 finding from 1 review
- Angiogenesis inhibitors for the treatment of epithelial ovarian cancer 2023 · Cochrane Headline outcomes onlyRR 1.11 [1.07, 1.16]3 studies · 1538 participantsHigh